Clinical Trial Update: EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN) [Phase 3]

View source ↗

Summary

Phase 3 trial of a novel ocular antiseptic for diabetic macular edema and branch retinal vein occlusion was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Diabetic Macular Edema

Drugs mentioned

• EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)

Snippet

Sponsor: iRenix Medical, Inc. | Conditions: Diabetic Macular Edema, Branch Retinal Vein Occlusion | Phase 3 | Status: TERMINATED